← 返回

肿瘤免疫中的 NK 细胞来源纳米囊泡

英文原题:NK cellular derived nanovesicles in tumor immunity.

查看英文原题

NK cellular derived nanovesicles in tumor immunity.

PubMed 2025/04/01(内容时间) Mol Immunol Q2 · IF 3.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

自然杀伤(NK)细胞是先天免疫系统的重要组成部分,基于 NK 细胞的疗法已显示对多种恶性肿瘤有效。然而,由于 NK 细胞难以浸润肿瘤,以及肿瘤可采用有效逃逸策略,靶向实体瘤仍然困难。近期研究显示,NK 细胞来源纳米囊泡(NK-NV)不仅可以复制 NK 细胞的功能,在临床应用方面还具有更多优势。NK-NV 能够远距离运输蛋白质、核酸和脂质等多种细胞成分,促进肿瘤微环境(TME)内不同细胞之间的通讯。随着纳米医学技术发展,这些囊泡可以经工程化改造,携带多种功能元件和治疗药物,以增强抗肿瘤能力。本综述总结现有 NK-NV 文献,讨论其潜在生物学功能及非编码 RNA(ncRNA)的作用,并探讨其用于实体瘤治疗的应用前景。

展开英文摘要原文

Natural Killer (NK) cells are a vital element of the innate immune system, and NK cell-based therapies have demonstrated efficacy against various malignancies.

However, targeting solid tumors has been challenging due to the low infiltration of NK cells into tumors and the effective evasion strategies employed by tumors. Recent studies have shown that NK cell derived nanovesicles (NK-NV) can not only replicate the functions of NK cells but also offer more advantages in clinical applications. They are capable of transporting various cellular components such as proteins, nucleic acids, and lipids across distances, thereby facilitating intercellular communication among various cells within the tumor microenvironment (TME).

With the progress in nanomedical technology, these vesicles can be engineered to carry a range of functional elements and therapeutic agents to enhance their antitumoral capabilities. In this review, we summarize the current available literature on NK-NVs, discuss their potential biological functions and the role of non-coding RNAs (ncRNAs), and explore their application in the treatment of solid tumors.

论文信息

作者
Li D、Shi Y、Yu S、Zhang B、Huang Z、Ling F、Mao X、Deng Y
第一作者单位
Institute of Translational Medicine, The First People's Hospital of Foshan, Guangdong, China; School of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong, China.China
通讯作者单位
Institute of Translational Medicine, The First People's Hospital of Foshan, Guangdong, China. Electronic address: luowei_421@163.com.China
文献类型
综述 · 非美国政府资助研究
期刊
Molecular immunology2025 Jun
原文标识
PubMed 40174421 · DOI 10.1016/j.molimm.2025.03.018